% Expired Patents = 75.0

EPO Patents = 1

Forward Citations = 0

Loading Chart...

8 inventors (with patents filed for the assignee):

Veronique Orian-Rousseau (3 out of 3 patents)

Alexandra Matzke (3 out of 5 patents)

Helmut Ponta (3 out of 5 patents)

4. Walter Mier (1 out of 22 patents)

5. Uwe Haberkorn (1 out of 20 patents)

6. Alexandra Matzke-Ogi (1 out of 1 patent)

7. Véronique Orian-Rousseau (1 out of 3 patents)

8. Thomas Lindner (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10703796 - CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases (2020-07-07),

2. 9593146 - CD44v6-derived peptides for treating metastasizing cancer (2017-03-14),

3. 9586994 - CD44V6-derived peptides for treating breast cancer (2017-03-07),

4. 9586993 - CD44v6-derived peptides for treating pancreatic cancer (2017-03-07),

Amcure is a German biopharmaceutical company specializing in the development of novel cancer therapeutics. Their innovative approach combines cutting-edge technology with deep scientific expertise to deliver next-generation treatments for cancer patients. With a focus on personalized medicine, Amcure is dedicated to improving the lives of those affected by cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

4 Patents

#4 in Eggenstein-Leopoldshafen

#7,041 in Germany

Eggenstein-Leopoldshafen, Germany

Amcure Gmbh